剖宫产瘢痕妊娠的发病率与复发:单中心三级转诊中心五年经验
该研究为耶鲁-纽黑文医院2013年5月至2018年3月的病例系列,描述了26例患者共30次剖宫产瘢痕妊娠的治疗及后续妊娠结局。治疗方式多样,部分患者发生复发,但正常妊娠亦可能。安全结局取决于及时诊断和多学科熟练临床医生的照护。
要点
- 26例患者共诊断30次剖宫产瘢痕妊娠,其中1例复发1次,另1例复发3次。
- 治疗方式包括全身和(或)局部甲氨蝶呤、氯化钾注射、子宫动脉栓塞、子宫内球囊等。
- 8例患者后续10次自然妊娠中,4次为复发性剖宫产瘢痕妊娠,4次足月产,1次自然流产。
核心结论
- 剖宫产瘢痕妊娠有多种治疗方式可供选择。
- 剖宫产瘢痕妊娠女性未来有复发风险,但剖宫产瘢痕妊娠后正常妊娠也是可能的。
- 安全结局取决于及时诊断和多学科熟练临床医生的照护。
研究设计与样本
- 本研究为病例系列,纳入2013年5月至2018年3月在耶鲁-纽黑文医院诊断的所有剖宫产瘢痕妊娠。
- 通过电子病历回顾收集患者人口学、病史、妊娠特征、治疗方式、治疗反应、并发症及后续妊娠结局。
主要发现
- 26例患者中共诊断30次剖宫产瘢痕妊娠,包括1例患者复发1次和另1例患者复发3次。
- 46%的剖宫产瘢痕妊娠发生于西班牙裔女性。
- 既往剖宫产次数的中位数为2次。
- 诊断时平均孕龄为46天(标准差±10)。
- 18例检测到胎心活动。
关键数值与推荐
- 3例患者最初被误诊为存活宫内妊娠,药物终止妊娠失败。
- 选择单纯全身甲氨蝶呤治疗者4例,全身联合局部甲氨蝶呤者12例,全身联合局部甲氨蝶呤并向妊娠囊内注射氯化钾者3例,氯化钾注射联合剖腹探查及楔形切除术者1例,甲氨蝶呤联合双侧子宫动脉栓塞者2例,或宫内球囊者4例。
- 5例接受期待管理或甲氨蝶呤治疗的患者发生妊娠物残留,需宫腔镜和刮宫术。
- 1例患者在刮宫失败后选择子宫切除术。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the treatment and subsequent pregnancy outcomes in patients with cesarean scar pregnancies at a single institution over 5 years. METHODS: This is a case series of all cesarean scar pregnancies diagnosed from May 2013 to March 2018 at Yale-New Haven Hospital. Data were collected on each patient using electronic medical record review and included patient demographics; medical, surgical, and obstetric history; pregnancy characteristics; treatment modalities used; response to therapy; complications; and subsequent pregnancy outcomes. RESULTS: Thirty cases of cesarean scar pregnancies were diagnosed in 26 patients, including one recurrence in one patient and three recurrences in another. Forty-six percent of cesarean scar pregnancies were in Hispanic women. The median number of prior cesarean deliveries was two. Mean gestational age at the time of diagnosis was 46 days (SD±10). Fetal cardiac activity was detected in 18 cases. Three patients initially were erroneously diagnosed with a viable intrauterine pregnancy and failed medical termination. Others opted for termination through systemic methotrexate alone (n=4), systemic and local methotrexate (n=12), systemic and local methotrexate with potassium chloride injected into the gestational sac (n=3), potassium chloride injection with laparotomy and wedge resection (n=1), methotrexate with bilateral uterine artery embolization (n=2), or intrauterine balloon (n=4). Five patients who underwent expectant management or methotrexate therapy had retained products of conception and required hysteroscopy and curettage. One patient opted for hysterectomy after failed curettage. After complete resolution of cesarean scar pregnancies, there were 10 subsequent spontaneous conceptions in eight patients, including four recurrent cesarean scar pregnancies, four term pregnancies, and one spontaneous abortion. One viable normally located pregnancy is ongoing. CONCLUSION: There is a wide array of treatment modalities available for cesarean scar pregnancies. Women with a cesarean scar pregnancy are at risk for its recurrence in the future, although normal pregnancy after a cesarean scar pregnancy is also possible. Safe outcomes depend on timely diagnosis and multidisciplinary care by skilled clinicians.
引用
- Grechukhina O, Deshmukh U, Fan L, et al. Cesarean Scar Pregnancy, Incidence, and Recurrence: Five-Year Experience at a Single Tertiary Care Referral Center. Obstet Gynecol. 2018. PMID: 30303911. doi:10.1097/AOG.0000000000002940
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。